Streetbeat News

Analyst Ratings

TTD

Morgan Stanley analyst Matthew Cost has maintained an Overweight rating on Trade Desk (NASDAQ:TTD) but has reduced the price target from $105 to $70.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:21 pm

MODG

Morgan Stanley analyst Megan Alexander has maintained an Underweight rating on Topgolf Callaway Brands (NYSE:MODG) and reduced the price target from $12.5 to $10.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:19 pm

NVMI

Benchmark analyst Mark Miller has maintained a Buy rating on Nova (NASDAQ:NVMI) but has reduced the price target from $135 to $125.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:19 pm

NVTS

Morgan Stanley analyst Joseph Moore has maintained an Equal-Weight rating on Navitas Semiconductor (NASDAQ:NVTS) but reduced the price target from $8 to $6.9.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:17 pm

NTRA

Morgan Stanley analyst Tejas Savant has maintained an Overweight rating on Natera (NASDAQ:NTRA) but reduced the price target from $70 to $68.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:16 pm

KORE

Morgan Stanley analyst Meta Marshall has maintained an Equal-Weight rating on Kore Group Holdings (NYSE:KORE) but reduced the price target from $1.5 to $0.7.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:14 pm

ONTO

Benchmark analyst Mark Miller has reiterated a Buy rating on Onto Innovation (NYSE:ONTO) and maintained a price target of $145.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:13 pm

IHRT

Morgan Stanley analyst Benjamin Swinburne has maintained an Underweight rating on iHeartMedia (NASDAQ:IHRT) and reduced the price target from $5 to $3.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:12 pm

GXO

Morgan Stanley analyst Ravi Shanker has maintained an Overweight rating on GXO Logistics (NYSE:GXO) but reduced the price target from $78 to $75.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:10 pm

GDRX

Morgan Stanley analyst Ricky Goldwasser has maintained an Equal-Weight rating on GoodRx Holdings (NASDAQ:GDRX) but reduced the price target from $8 to $5.5.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:08 pm